Heska Corp (NASDAQ:HSKA)

102.20
Delayed Data
As of May 18
 -0.23 / -0.22%
Today’s Change
56.59
Today|||52-Week Range
115.00
+27.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$704.4M

Company Description

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines, and Pharmaceuticals and Products segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Contact Information

Heska Corp.
3760 Rocky Mountain Avenue
Loveland Colorado 80538
P:(970) 493-7272
Investor Relations:
(970) 619-3033

Employees

Shareholders

Other institutional45.45%
Mutual fund holders43.96%
Individual stakeholders19.03%

Top Executives

Kevin S. WilsonPresident, Chief Executive Officer & Director
Jason A. NapolitanoCOO, Secretary & Chief Strategist
Catherine GrassmanChief Accounting Officer, VP & Controller
Nancy WisnewskiEVP-Diagnostic Operations & Product Development
Michael John McGinleyPresident-Biologicals & Pharmaceuticals